The Clover Key Bioscience team, represented by the CEO, Branimir Brankov, MD, PhD, MBA, Milena Brankov, MPh, MBA, and Murali Parthasarathy, MS, MBA, attended the JPM Healthcare Conference in San Francisco, CA, from Jan. 10-15, 2026, to present the company and establish business contacts to further the development of our product that improves mitochondrial quality control and has anti-inflammatory and neuroprotective activities.
